InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

FENNEC PHARMACEUTICALS INC.

FENC Clue Score47
United States Fiscal year ends December CIK 0001211583 Results filed 24 Mar 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

33
Insider
Date
Role
Action
Shares
Price
Amount
Marco Maria Brughera
15 Sep 2026
Director
Sold after exercise
15,545
$10.29
$159.96K
Rosty Raykov
1 Jul 2026
Former Director
Sold after exercise
9,599
$10.41
$99.93K
Rosty Raykov
1 Jun 2026
Director
Sold after exercise
9,747
$9.62
$93.77K
Chris A Rallis
11 May 2026
Director
Sold after exercise
8,346
$7.04
$58.76K
Rosty Raykov
1 May 2026
Director
Sold after exercise
10,781
$6.47
$69.75K
Rosty Raykov
1 Apr 2026
Director
Sold after exercise
10,946
$6.31
$69.07K
Rosty Raykov
2 Mar 2026
Director
Sold after exercise
10,079
$8.36
$84.26K
Rosty Raykov
2 Feb 2026
Director
Sold after exercise
10,349
$7.76
$80.31K
Rosty Raykov
2 Jan 2026
Director
Sold after exercise
10,312
$7.60
$78.37K
Chris A Rallis
10 Oct 2025
Director
Sold after exercise
1,775
$9.24
$16.40K
Chris A Rallis
7 Jul 2025
Director
Sold after exercise
1,119
$8.71
$9.75K
Chris A Rallis
11 Apr 2025
Director
Sold after exercise
1,409
$4.95
$6.97K
Chris A Rallis
14 Feb 2025
Director
Sold after exercise
1,186
$6.82
$8.09K
Chris A Rallis
2 Dec 2024
Director
Sold after exercise
6,409
$6.14
$39.35K
Chris A Rallis
8 Oct 2024
Director
Sold after exercise
1,406
$4.53
$6.37K
Chris A Rallis
5 Jul 2024
Director
Sold after exercise
1,173
$6.03
$7.07K
Adrian Haigh
22 Apr 2024
Chief Operating Officer
Sold after exercise
22,223
$9.32
$207.03K
Adrian Haigh
19 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$9.34
$207.44K
Adrian Haigh
18 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$9.62
$213.78K
Adrian Haigh
18 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$2.31
$51.33K
Adrian Haigh
17 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$9.91
$220.22K
Adrian Haigh
17 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$2.31
$51.33K
Adrian Haigh
16 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$10.28
$228.39K
Adrian Haigh
16 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$2.31
$51.33K
Chris A Rallis
15 Apr 2024
Director
Sold after exercise
800
$10.45
$8.36K
Adrian Haigh
15 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$10.30
$228.79K
Adrian Haigh
15 Apr 2024
Chief Operating Officer
Sold after exercise
22,222
$2.31
$51.33K
Chris A Rallis
26 Mar 2024
Director
Sold after exercise
2,114
$10.97
$23.19K
Rosty Raykov
28 Dec 2023
Chief Executive Officer
Sold after exercise
3,656
$11.55
$42.23K
Chris A Rallis
26 Dec 2023
Director
Sold after exercise
1,390
$10.90
$15.15K
Chris A Rallis
24 Jul 2023
Director
Sold after exercise
6,796
$8.17
$55.52K
Chris A Rallis
6 Jul 2023
Director
Sold after exercise
2,207
$8.47
$18.69K
Robert Andrade
30 Jun 2023
Chief Financial Officer
Sold after exercise
7,500
$8.82
$66.15K
Show all 196 transactions →

What was left out

Form 4 filings counted 262
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 36
Sales straight out of an exercise 33
Sales at will 54
Transactions with no price 0
Shares from compensation/vesting 2,375,233
Sales filed before the plan box existed 39
History held since 2 May 2007